Context Therapeutics (CNTX) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Context Therapeutics (CNTX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 7.02M (-40.71%) | 12M (+35.78%) | 8.72M (+11.37%) | 7.83M (+126.30%) | 3.46M (+37.30%) | 2.52M (-85.03%) | 17M (+1119.57%) | 1.38M (-29.95%) | 1.97M (-62.83%) | 5.30M (+18.04%) | 4.49M (+29.77%) | 3.46M (-23.62%) | 4.53M (+111.68%) | 2.14M (+2.88%) | 2.08M (+36.84%) | 1.52M (+12.59%) | 1.35M (+4.65%) | 1.29M (+74.32%) | 740K (-44.36%) | 1.33M (+202.27%) | 440K (-62.39%) | 1.17M (+148.94%) | 470K | - | - |
Selling General And Administrative | 2.33M (+18.88%) | 1.96M (+3.70%) | 1.89M (-2.07%) | 1.93M (-6.76%) | 2.07M (+15.64%) | 1.79M (-4.79%) | 1.88M (+10.59%) | 1.70M (-8.11%) | 1.85M (+13.50%) | 1.63M (-4.12%) | 1.70M (-7.10%) | 1.83M (-14.08%) | 2.13M (+22.41%) | 1.74M (-11.68%) | 1.97M (-1.01%) | 1.99M (-4.78%) | 2.09M (+16.11%) | 1.80M (+116.87%) | 830K (+38.33%) | 600K (+50.00%) | 400K (-46.67%) | 750K (+316.67%) | 180K | - | - |
Operating Expenses | 9.34M (-32.32%) | 14M (+30.07%) | 11M (+8.71%) | 9.76M (+76.49%) | 5.53M (+28.31%) | 4.31M (-76.95%) | 19M (+505.18%) | 3.09M (-19.11%) | 3.82M (-44.88%) | 6.93M (+12.14%) | 6.18M (+16.82%) | 5.29M (-20.69%) | 6.67M (+71.91%) | 3.88M (-4.20%) | 4.05M (+15.38%) | 3.51M (+2.03%) | 3.44M (+11.33%) | 3.09M (+96.82%) | 1.57M (-19.07%) | 1.94M (+130.95%) | 840K (-56.25%) | 1.92M (+195.38%) | 650K | - | - |
Depreciation And Amortization | - | 10K | - | - | - | 10K | - | - | - | 10K | - | - | - | 10K | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | |||||||||||||||||||||||||
Operating Income | -9.34M (-32.32%) | -13.80M (+30.07%) | -10.61M (+8.71%) | -9.76M (+76.49%) | -5.53M (+28.31%) | -4.31M (-76.95%) | -18.70M (+505.18%) | -3.09M (-19.11%) | -3.82M (-44.88%) | -6.93M (+12.14%) | -6.18M (+16.82%) | -5.29M (-20.69%) | -6.67M (+71.91%) | -3.88M (-4.20%) | -4.05M (+1.00%) | -4.01M (+16.57%) | -3.44M (+11.33%) | -3.09M (+96.82%) | -1.57M (-68.79%) | -5.03M (+498.81%) | -840.00K (-56.25%) | -1.92M (+195.38%) | -650.00K | - | - |
Ebit | -9.34M (-32.32%) | -13.80M (+30.07%) | -10.61M (+8.71%) | -9.76M (+76.49%) | -5.53M (+28.31%) | -4.31M (-76.95%) | -18.70M (+505.18%) | -3.09M (-19.11%) | -3.82M (-44.88%) | -6.93M (+12.14%) | -6.18M (+16.82%) | -5.29M (-20.69%) | -6.67M (+71.91%) | -3.88M (-4.20%) | -4.05M (+1.00%) | -4.01M (+16.57%) | -3.44M (+11.33%) | -3.09M (+96.82%) | -1.57M (-68.79%) | -5.03M (+498.81%) | -840.00K (-91.79%) | -10.23M (+1473.85%) | -650.00K | 7.48M (+801.20%) | 830K |
EBITDA | -9.34M (-40.28%) | -15.64M (+61.40%) | -9.69M (+9.74%) | -8.83M (+59.67%) | -5.53M (-13.32%) | -6.38M (-63.46%) | -17.46M (+676.00%) | -2.25M (-41.10%) | -3.82M (-49.13%) | -7.51M (+27.94%) | -5.87M (+17.17%) | -5.01M (-24.77%) | -6.66M (+62.84%) | -4.09M (+6.23%) | -3.85M (-3.51%) | -3.99M (+15.99%) | -3.44M (+8.86%) | -3.16M (+119.44%) | -1.44M (-71.37%) | -5.03M (+465.17%) | -890.00K (+304.55%) | -220.00K (-71.79%) | -780.00K | 7.48M (+801.20%) | 830K |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Income | 520K (-23.53%) | 680K (-18.07%) | 830K (-7.78%) | 900K (-6.25%) | 960K (0.00%) | 960K (-22.58%) | 1.24M (+47.62%) | 840K (+460.00%) | 150K (-87.07%) | 1.16M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 60K | - | - | - | 570K (+470.00%) | 100K | - | - |
Net Interest Income | 520K (-23.53%) | 680K (-18.07%) | 830K (-7.78%) | 900K (-6.25%) | 960K (0.00%) | 960K (-22.58%) | 1.24M (+47.62%) | 840K (+460.00%) | 150K (-87.07%) | 1.16M | - | - | - | - | - | - | - | -60.00K | - | - | - | -570.00K (+470.00%) | -100.00K | - | - |
Other Non Operating Income | 140K (-30.00%) | 200K (+150.00%) | 80K (+166.67%) | 30K | -10.00K | - | - | -10.00K | - | -60.00K | 20K | -10.00K | - | - | - | - | - | 120K (-7.69%) | 130K | - | - | - | - | - | - |
Net Income | |||||||||||||||||||||||||
Net Income From Continuing Operations | -8.68M (-33.38%) | -13.03M (+34.47%) | -9.69M (+9.74%) | -8.83M (+92.79%) | -4.58M (+37.13%) | -3.34M (-80.87%) | -17.46M (+676.00%) | -2.25M (-38.69%) | -3.67M (-45.79%) | -6.77M (+15.33%) | -5.87M (+17.17%) | -5.01M (-20.60%) | -6.31M (+77.25%) | -3.56M (-7.53%) | -3.85M (-3.51%) | -3.99M (+15.99%) | -3.44M (+11.33%) | -3.09M (+114.58%) | -1.44M (-71.37%) | -5.03M (+465.17%) | -890.00K (+14.10%) | -780.00K (-11.36%) | -880.00K | 7.48M (+801.20%) | 830K |
Net Income | -8.68M (-33.38%) | -13.03M (+34.47%) | -9.69M (+9.74%) | -8.83M (+92.79%) | -4.58M (+37.13%) | -3.34M (-80.87%) | -17.46M (+676.00%) | -2.25M (-38.69%) | -3.67M (-45.79%) | -6.77M (+15.33%) | -5.87M (+17.17%) | -5.01M (-20.60%) | -6.31M (+77.25%) | -3.56M (-7.53%) | -3.85M (-3.51%) | -3.99M (+15.99%) | -3.44M (+11.33%) | -3.09M (+114.58%) | -1.44M (-71.37%) | -5.03M (+465.17%) | -890.00K (+14.10%) | -780.00K (-11.36%) | -880.00K | 7.48M (+801.20%) | 830K |